{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:58:47Z","timestamp":1782327527310,"version":"3.54.5"},"publisher-location":"Cham","reference-count":87,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319442501","type":"print"},{"value":"9783319442518","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/5584_2016_76","type":"book-chapter","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T12:33:34Z","timestamp":1480077214000},"page":"239-259","source":"Crossref","is-referenced-by-count":50,"title":["Phaeochromocytoma and Paraganglioma"],"prefix":"10.1007","author":[{"given":"P.T. Kavinga","family":"Gunawardane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"76_CR1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1210\/jc.2004-1398","volume":"90","author":"L Amar","year":"2005","unstructured":"Amar L, Servais A, Gimeniz-Roqueplo AP et al (2005) Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 90:2110\u20132116","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"76_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ctrv.2010.07.002","volume":"37","author":"KF Andersen","year":"2011","unstructured":"Andersen KF, Altaf R, Krarup-Hansen A et al (2011) Malignant pheochromocytomas and paragangliomas\u2014the importance of a multidisciplinary approach. Cancer Treat Rev 37(2):111\u2013119","journal-title":"Cancer Treat Rev"},{"key":"76_CR3","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/bjs.4738","volume":"91","author":"A Assalia","year":"2004","unstructured":"Assalia A, Gagner M (2004) Laparoscopic adrenalectomy. Br J Surg 91:1259\u20131274","journal-title":"Br J Surg"},{"key":"76_CR4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1530\/eje.0.1500681","volume":"150","author":"JP Baguet","year":"2004","unstructured":"Baguet JP, Hammer L, Mazzuco TL et al (2004) Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients. Eur J Endocrinol 150:681","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"76_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.7326\/0003-4819-150-1-200901060-00006","volume":"150","author":"SK Baid","year":"2009","unstructured":"Baid SK, Lai EW, Wesley RA, Ling A, Timmers HJ, Adams KT, Kozupa A, Pacak K (2009) Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma. Ann Intern Med 150(1):27\u201332. Erratum in: Ann Intern Med. 2009 Feb 17;150(4):292","journal-title":"Ann Intern Med"},{"key":"76_CR6","doi-asserted-by":"publisher","unstructured":"Barnes L, Taylor SR (1990) Carotid body paragangliomas. A clinicopathologic and DNA analysis of 13 tumors. Arch Otolaryngol Head Neck Surg 116","DOI":"10.1001\/archotol.1990.01870040069016"},{"key":"76_CR7","first-page":"802","volume":"58","author":"CM Beard","year":"1983","unstructured":"Beard CM, Sheps SG, Kurland LT et al (1983) Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 58:802","journal-title":"Mayo Clin Proc"},{"key":"76_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/0735-6757(89)90084-3","volume":"7","author":"BE Bergland","year":"1989","unstructured":"Bergland BE (1989) Pheochromocytoma presenting as shock. Am J Emerg Med 7:44\u201348","journal-title":"Am J Emerg Med"},{"key":"76_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1365-2796.2001.00792.x","volume":"249","author":"AS Berglund","year":"2001","unstructured":"Berglund AS, Hulth\u00e9n UL, Manhem P, Thorsson O, Wollmer P, T\u00f6rnquist C (2001) Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas. J Intern Med 249:247\u2013251","journal-title":"J Intern Med"},{"key":"76_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1365-2265.2008.03256.x","volume":"69","author":"KS Bhatia","year":"2008","unstructured":"Bhatia KS, Ismail MM, Sahdev A et al (2008) 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Clin Endocrinol (Oxf) 69:181\u2013188","journal-title":"Clin Endocrinol (Oxf)"},{"key":"76_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1148\/rg.24si045506","volume":"24","author":"MA Blake","year":"2004","unstructured":"Blake MA et al (2004) Pheochromocytoma. An Imaging Chameleon. Radiographics 24:87\u201399","journal-title":"Radiographics"},{"key":"76_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/ki.1991.244","volume":"40","author":"EL Bravo","year":"1991","unstructured":"Bravo EL (1991) Pheochromocytoma: new concepts and future trends. Kidney Int 40:544","journal-title":"Kidney Int"},{"issue":"3","key":"76_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/cen.12530","volume":"82","author":"JP Brito","year":"2015","unstructured":"Brito JP, Asi N, Bancos I, Gionfriddo MR, Zeballos-Palacios CL, Leppin AL, Undavalli C, Wang Z, Domecq JP, Prustsky G, Elraiyah TA, Prokop LJ, Montori VM, Murad MH (2015) Testing for germline mutations in sporadic pheochromocytoma\/paraganglioma: a systematic review. Clin Endocrinol (Oxf) 82(3):338\u2013345. doi: 10.1111\/cen.12530 , Epub 2014 Jul 7","journal-title":"Clin Endocrinol (Oxf)"},{"key":"76_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.surg.2008.08.032","volume":"144","author":"L Brunaud","year":"2008","unstructured":"Brunaud L, Ayav A, Zarnegar R et al (2008) Prospective evaluation of 100 robotic-assisted unilateral adrenalectomies. Surgery 144:995\u20131001","journal-title":"Surgery"},{"issue":"10","key":"76_CR15","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s00259-007-0450-1","volume":"34","author":"I Buchmann","year":"2007","unstructured":"Buchmann I, Henze M, Engelbrecht S et al (2007) Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 34(10):1617\u20131626","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"76_CR16","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ng.861","volume":"43","author":"I Comino-Mendez","year":"2011","unstructured":"Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F et al (2011) Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43:663\u2013777","journal-title":"Nat Genet"},{"issue":"4","key":"76_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/cen.12327","volume":"80","author":"R D\u00e4rr","year":"2014","unstructured":"D\u00e4rr R, Pamporaki C, Peitzsch M, Miehle K, Prejbisz A et al (2014) Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions. Clin Endocrinol (Oxf) 80(4):478\u2013486. doi: 10.1111\/cen.12327","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"76_CR18","doi-asserted-by":"publisher","first-page":"E531","DOI":"10.1210\/jc.2014-3399","volume":"100","author":"J D\u00e9nes","year":"2015","unstructured":"D\u00e9nes J, Swords F, Rattenberry E, Stals K, Owens M, Cranston T, Xekouki P, Moran L, Kumar A, Wassif C, Fersht N, Baldeweg SE, Morris D, Lightman S, Agha A, Rees A, Grieve J, Powell M, Boguszewski CL, Dutta P, Thakker RV, Srirangalingam U, Thompson CJ, Druce M, Higham C, Davis J, Eeles R, Stevenson M, O\u2019Sullivan B, Taniere P, Skordilis K, Gabrovska P, Barlier A, Webb SM, Aulinas A, Drake WM, Bevan JS, Preda C, Dalantaeva N, Ribeiro-Oliveira A Jr, Garcia IT, Yordanova G, Iotova V, Evanson J, Grossman AB, Trouillas J, Ellard S, Stratakis CA, Maher ER, Roncaroli F, Korbonits M (2015) Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma: results from a large patient cohort. J Clin Endocrinol Metab 100(3):E531\u2013E541. doi: 10.1210\/jc.2014-3399 , Epub 2014 Dec 12","journal-title":"J Clin Endocrinol Metab"},{"key":"76_CR19","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1056\/NEJM200205093461911","volume":"346","author":"RG Dluhy","year":"2002","unstructured":"Dluhy RG (2002) Pheochromocytoma-death of an axiom. N Engl J Med 346:1486","journal-title":"N Engl J Med"},{"issue":"9","key":"76_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1055\/s-0029-1220687","volume":"41","author":"MR Druce","year":"2009","unstructured":"Druce MR, Kaltsas GA, Fraenkel M, Gross DJ, Grossman AB (2009) Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001). Horm Metab Res 41(9):697\u2013702. doi: 10.1055\/s-0029-1220687 , Epub 2009 May 7","journal-title":"Horm Metab Res"},{"key":"76_CR21","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11906-012-0246-y","volume":"14","author":"G Eisenhofer","year":"2012","unstructured":"Eisenhofer G (2012) Screening for pheochromocytomas and paragangliomas. Curr Hypertens Rep 14:130\u2013137. doi: 10.1007\/s11906-012-0246-y","journal-title":"Curr Hypertens Rep"},{"key":"76_CR22","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","volume":"86","author":"G Eisenhofer","year":"2001","unstructured":"Eisenhofer G, Walther MM, Huynh TT et al (2001) Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab 86:1999","journal-title":"J Clin Endocrinol Metab"},{"key":"76_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1124\/pr.56.3.1","volume":"56","author":"G Eisenhofer","year":"2004","unstructured":"Eisenhofer G, Kopin IJ, Goldstein DS (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56:331\u2013349","journal-title":"Pharmacol Rev"},{"issue":"11","key":"76_CR24","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","volume":"48","author":"G Eisenhofer","year":"2012","unstructured":"Eisenhofer G et al (2012) Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status. Eur J Cancer 48(11):1739\u20131749","journal-title":"Eur J Cancer"},{"key":"76_CR25","doi-asserted-by":"publisher","unstructured":"Ferreira VM, Marcelino M, Piechnik SK, Marini C, Karamitsos TD, Ntusi NAB, Francis JM, Robson MD, Arnold JR, Mihai R, Thomas JD, Herincs M, Hassan-Smith Z, Karavitaki N, Greiser A, Arlt W, Korbonits M, Grossman A, Wass J, Neubauer S (2016) Pheochromocytoma is characterized by catecholamine myocarditis, focal and diffuse fibrosis, and persistent subclinical systolic and diastolic dysfunction. J Am Coll Cardiol, in press","DOI":"10.1016\/j.jacc.2016.03.543"},{"issue":"4","key":"76_CR26","first-page":"334","volume":"52","author":"F Forrer","year":"2008","unstructured":"Forrer F, Riedweg I, Maecke HR, Mueller-Brand J (2008) Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma. Q J Nucl Med Mol Imaging 52(4):334\u2013340","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"2","key":"76_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/cen.12071","volume":"78","author":"SR Galan","year":"2013","unstructured":"Galan SR, Kann PH (2013) Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma. Clin Endocrinol (Oxf) 78(2):165\u2013175","journal-title":"Clin Endocrinol (Oxf)"},{"key":"76_CR28","first-page":"313","volume":"39","author":"H Grosse","year":"1990","unstructured":"Grosse H, Schr\u00f6der D, Schober O, Hausen B, Dralle H (1990) The importance of high-dose alpha-receptor blockade for blood volume and hemodynamics in pheochromocytoma [in German]. Anaesthesist 39:313\u2013318","journal-title":"Anaesthesist"},{"key":"76_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1196\/annals.1353.038","volume":"1073","author":"A Grossman","year":"2006","unstructured":"Grossman A, Pacak K, Sawka A et al (2006) Biochemical diagnosis and localization of pheochromocytoma: can we reach a consensus? Ann N Y Acad Sci 1073:332\u2013347","journal-title":"Ann N Y Acad Sci"},{"key":"76_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jamcollsurg.2009.09.022","volume":"209","author":"MA Guerrero","year":"2009","unstructured":"Guerrero MA, Schreinemakers JM, Vriens MR et al (2009) Clinical spectrum of pheochromocytoma. J Am Coll Surg 209:727","journal-title":"J Am Coll Surg"},{"issue":"11","key":"76_CR31","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1002\/ijc.28913","volume":"135","author":"J Hadoux","year":"2014","unstructured":"Hadoux J, Favier J, Scoazec JY, Leboulleux S, Al Ghuzlan A et al (2014) SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma. Int J Cancer 135(11):2711\u20132720. doi: 10.1002\/ijc.28913","journal-title":"Int J Cancer"},{"issue":"12","key":"76_CR32","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s002590100639","volume":"28","author":"M Hofmann","year":"2001","unstructured":"Hofmann M, Maecke H, Bo \u0308rner AR et al (2001) Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data. Eur J Nucl Med 28(12):1751\u20131757","journal-title":"Eur J Nucl Med"},{"issue":"9","key":"76_CR33","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1210\/jc.2003-030235","volume":"88","author":"I Ilias","year":"2003","unstructured":"Ilias I, Yu J, Carrasquillo JA et al (2003) Superiority of 6- [18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma. J Clin Endocrinol Metab 88(9):4083\u20134087","journal-title":"J Clin Endocrinol Metab"},{"key":"76_CR34","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1210\/jc.2009-2604","volume":"95","author":"AF Jacobson","year":"2010","unstructured":"Jacobson AF, Deng H, Lombard J, Lessig HJ, Black RR (2010) 123I -meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis. J Clin Endocrinol Metab 95:2596\u20132606","journal-title":"J Clin Endocrinol Metab"},{"key":"76_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/110241598750004913","volume":"164","author":"ND Jalil","year":"1998","unstructured":"Jalil ND, Pattou FN, Combemale F et al (1998) Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE). Eur J Surg 164:23\u201328","journal-title":"Eur J Surg"},{"issue":"17","key":"76_CR36","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","volume":"21","author":"I Janssen","year":"2015","unstructured":"Janssen I, Blanchet EM, Adams K et al (2015) Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma. Clin Cancer Res 21(17):3888\u20133895. doi: 10.1158\/1078-0432.CCR-14-2751","journal-title":"Clin Cancer Res"},{"issue":"3","key":"76_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.beem.2010.04.001","volume":"24","author":"V Kantorovich","year":"2010","unstructured":"Kantorovich V, King KS, Pacak K (2010) SDH-related pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab 24(3):415\u2013424. doi: 10.1016\/j.beem.2010.04.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"76_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1385\/EP:16:1:023","volume":"16","author":"N Kimura","year":"2005","unstructured":"Kimura N, Watanabe T, Noshiro T, Shizawa S, Miura Y (2005) Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 16(1):23\u201332","journal-title":"Endocr Pathol"},{"key":"76_CR39","first-page":"1209","volume":"113","author":"KE Kliewer","year":"1989","unstructured":"Kliewer KE, Cochran AJ (1989) A review of the histology, ultrastructure, immunohistology, and molecular biology of extra-adrenal paragangliomas. Arch Pathol Lab Med 113:1209","journal-title":"Arch Pathol Lab Med"},{"key":"76_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0046-8177(89)90199-8","volume":"20","author":"KE Kliewer","year":"1989","unstructured":"Kliewer KE, Wen DR, Cancilla PA, Cochran AJ (1989) Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques. Hum Pathol 20:29","journal-title":"Hum Pathol"},{"key":"76_CR41","first-page":"191","volume":"87","author":"S Kocak","year":"2002","unstructured":"Kocak S, Aydintug S, Canakci N (2002) Alpha blockade in preoperative preparation of patients with pheochromocytomas. Int Surg 87:191\u2013194","journal-title":"Int Surg"},{"issue":"3","key":"76_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12020-011-9545-3","volume":"40","author":"TI Korevaar","year":"2011","unstructured":"Korevaar TI, Grossman AB (2011) Pheochromocytomas and paragangliomas: assessment of malignant potential. Endocrine 40(3):354\u2013365. doi: 10.1007\/s12020-011-9545-3 , Epub 2011 Oct 25","journal-title":"Endocrine"},{"key":"76_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1200\/JCO.2005.03.6046","volume":"24","author":"MH Kulke","year":"2006","unstructured":"Kulke MH, Stuart K, Enzinger PC, Ryan DP, Clark JW et al (2006) Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. J Clin Oncol 24:401\u2013406","journal-title":"J Clin Oncol"},{"issue":"13","key":"76_CR44","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1200\/JCO.2007.15.2553","volume":"26","author":"DJ Kwekkeboom","year":"2008","unstructured":"Kwekkeboom DJ, De Herder WW, Kam BL et al (2008) Treatment with the radiolabeled somatostatin analog [177Lu- DOTA0, Tyr3]octreotate: toxicity, efficacy, and survival. J Clin Oncol 26(13):2124\u20132130","journal-title":"J Clin Oncol"},{"key":"76_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","volume":"366","author":"JW Lenders","year":"2005","unstructured":"Lenders JW, Eisenhofer G, Mannelli M, Pacak K (2005) Phaeochromocytoma. Lancet 366:665\u2013675","journal-title":"Lancet"},{"issue":"6","key":"76_CR46","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1210\/jc.2014-1498","volume":"99","author":"JWM Lenders","year":"2014","unstructured":"Lenders JWM, Duh QY et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(6):1915\u20131942","journal-title":"J Clin Endocrinol Metab"},{"key":"76_CR47","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1053\/ajem.2000.7341","volume":"18","author":"WB Liao","year":"2000","unstructured":"Liao WB, Liu CF, Chiang CW et al (2000) Cardiovascular manifestations of pheochromocytoma. Am J Emerg Med 18:622\u2013625","journal-title":"Am J Emerg Med"},{"issue":"11","key":"76_CR48","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/0046-8177(90)90155-X","volume":"21","author":"RI Linnoila","year":"1990","unstructured":"Linnoila RI, Keiser HR, Steinberg SM, Lack EE (1990) Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 21(11):1168\u20131180","journal-title":"Hum Pathol"},{"issue":"3","key":"76_CR49","first-page":"198","volume":"33","author":"TH Liu","year":"2004","unstructured":"Liu TH, Chen YJ, Wu SF et al (2004) Distinction between benign and malignant pheochromocytomas. Zhonghua Bing Li Xue Za Zhi 33(3):198\u2013202","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"11","key":"76_CR50","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/BF03348026","volume":"20","author":"KC Loh","year":"1997","unstructured":"Loh KC, Fitzgerald PA, Matthay KK, Yeo PPB, Price DC (1997) The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Investig 20(11):648\u2013658","journal-title":"J Endocrinol Investig"},{"issue":"8","key":"76_CR51","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/jso.21196","volume":"100","author":"SK Maithel","year":"2009","unstructured":"Maithel SK, Fong Y (2009) Hepatic ablation for neuroendocrine tumor metastases. J Surg Oncol 100(8):635\u2013638","journal-title":"J Surg Oncol"},{"key":"76_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-1-59259-757-4_14","volume-title":"Secondary hypertension","author":"CD Malchoff","year":"2004","unstructured":"Malchoff CD, MacGillivray D, Shichman S (2004) Pheochromocytoma treatment. In: Mansoor GA (ed) Secondary hypertension. Humana Press, Totowa, pp 235\u2013249"},{"issue":"1","key":"76_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/01.mnm.0000189780.54658.e8","volume":"27","author":"M Mamede","year":"2006","unstructured":"Mamede M et al (2006) Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [123I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites. Nucl Med Commun 27(1):31\u201336","journal-title":"Nucl Med Commun"},{"key":"76_CR54","first-page":"637","volume":"85","author":"F Mantero","year":"2000","unstructured":"Mantero F, Terzolo M, Arnaldi G et al (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637\u2013644","journal-title":"J Clin Endocrinol Metab"},{"key":"76_CR55","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/3-540-26861-8_28","volume-title":"Adrenal glands: diagnostic aspects and surgical therapy","author":"SG Memtsoudis","year":"2005","unstructured":"Memtsoudis SG, Swamidoss C, Psoma M (2005) Anesthesia for adrenal surgery. In: Linos D, van Heerden JA (eds) Adrenal glands: diagnostic aspects and surgical therapy. Springer, New York, pp 287\u2013297"},{"key":"76_CR56","first-page":"1138","volume":"35","author":"PD Mozley","year":"1994","unstructured":"Mozley PD, Kim CK, Mohsin J et al (1994) The efficacy of iodine-123- MIBG as a screening test for pheochromocytoma. J Nucl Med 35:1138\u20131144","journal-title":"J Nucl Med"},{"key":"76_CR57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1148\/radiology.202.1.8988215","volume":"202","author":"JJ Mukherjee","year":"1997","unstructured":"Mukherjee JJ, Peppercorn PD, Reznek RH et al (1997) Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels. Radiology 202:227\u2013231","journal-title":"Radiology"},{"key":"76_CR58","first-page":"1989","volume":"80","author":"LM Mulligan","year":"1995","unstructured":"Mulligan LM, Ponder BA (1995) Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 80:1989","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"76_CR59","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1210\/jc.2011-1718","volume":"96","author":"K Nakamura","year":"2011","unstructured":"Nakamura K, Ogata M, Ando T, Usa T, Kawakami A (2011) Paroxysmal thyroid swelling. A forgotten clinical finding of pheochromocytoma. J Clin Endocrinol Metab 96(12):3601\u20133602","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"76_CR60","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s00330-011-2289-x","volume":"22","author":"N Naswa","year":"2012","unstructured":"Naswa N, Sharma P, Nazar AH, Agarwal KK, Kumar R, Ammini AC, Malhotra A, Bal C (2012) Prospective evaluation of 68Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study. Eur Radiol 22(3):710\u2013719","journal-title":"Eur Radiol"},{"key":"76_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMc1101502","volume":"364","author":"N Neary","year":"2011","unstructured":"Neary N, King KS, Pack K (2011) Drugs and pheochromocytoma\u2014don\u2019t be fooled by every elevated metanephrine. N Engl J Med 364:23","journal-title":"N Engl J Med"},{"key":"76_CR62","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.292.8.943","volume":"292","author":"HP Neumann","year":"2004","unstructured":"Neumann HP, Pawlu C, Peczkowska M et al (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292:943","journal-title":"JAMA"},{"issue":"2","key":"76_CR63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1530\/JME-12-0028","volume":"49","author":"S N\u00f6lting","year":"2012","unstructured":"N\u00f6lting S, Garcia E, Alusi G, Giubellino A, Pacak K, Korbonits M, Grossman AB (2012) Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines. J Mol Endocrinol 49(2):79\u201396. doi: 10.1530\/JME-12-0028","journal-title":"J Mol Endocrinol"},{"issue":"12","key":"76_CR64","doi-asserted-by":"publisher","first-page":"e0143830","DOI":"10.1371\/journal.pone.0143830","volume":"10","author":"S N\u00f6lting","year":"2015","unstructured":"N\u00f6lting S, Maurer J, Sp\u00f6ttl G, Aristizabal Prada ET, Reuther C, Young K, Korbonits M, G\u00f6ke B, Grossman A, Auernhammer CJ (2015) Additive anti-tumor effects of lovastatin and everolimus in vitro through simultaneous inhibition of signaling pathways. PLoS ONE 10(12):e0143830. doi: 10.1371\/journal.pone.0143830 , eCollection 2015","journal-title":"PLoS ONE"},{"key":"76_CR65","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1210\/jc.2007-1720","volume":"92","author":"K Pacak","year":"2007","unstructured":"Pacak K (2007) Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 92:4069\u20134079","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"76_CR66","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ncpendmet0396","volume":"3","author":"K Pacak","year":"2007","unstructured":"Pacak K, Eisenhofer G, Ahlman H et al (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab 3(2):92\u2013102","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"76_CR67","doi-asserted-by":"publisher","first-page":"872713","DOI":"10.1155\/2012\/872713","volume":"2012","author":"G Parenti","year":"2012","unstructured":"Parenti G, Zampetti B, Rapizzi E, Ercolino T, Giach\u00e8 V, Mannelli M (2012) Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma\/paraganglioma. J Oncol 2012:872713, 10 pages. doi: 10.1155\/2012\/872713","journal-title":"J Oncol"},{"key":"76_CR68","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1365-2265.2007.02805.x","volume":"66","author":"CG Perry","year":"2007","unstructured":"Perry CG, Sawka AM, Singh R, Thabane L, Bajnarek J, Young WF Jr (2007) The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma. Clin Endocrinol (Oxf) 66:703\u2013708","journal-title":"Clin Endocrinol (Oxf)"},{"key":"76_CR69","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1365-2265.1998.3751208.x","volume":"48","author":"FJ Pomares","year":"1998","unstructured":"Pomares FJ, Ca\u00f1as R, Rodriguez JM et al (1998) Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma. Clin Endocrinol (Oxf) 48:195","journal-title":"Clin Endocrinol (Oxf)"},{"key":"76_CR70","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00268-002-6667-z","volume":"26","author":"C Prys-Roberts","year":"2002","unstructured":"Prys-Roberts C, Farndon JR (2002) Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg 26:1037\u20131042","journal-title":"World J Surg"},{"issue":"6","key":"76_CR71","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1210\/jc.2012-1061","volume":"97","author":"T Sane","year":"2012","unstructured":"Sane T, Schalin-J\u00e4ntti C, Raade M (2012) Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary? J Clin Endocrinol Metab 97(6):2077\u20132083. doi: 10.1210\/jc.2012-1061 , Epub 2012 Apr 6","journal-title":"J Clin Endocrinol Metab"},{"key":"76_CR72","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1210\/jc.2002-021251","volume":"88","author":"AM Sawka","year":"2003","unstructured":"Sawka AM, Jaeschke R, Singh RJ et al (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88:553\u2013558","journal-title":"J Clin Endocrinol Metab"},{"key":"76_CR73","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/archinte.1997.00440290087009","volume":"157","author":"J Steinsapir","year":"1997","unstructured":"Steinsapir J, Carr AA, Prisant LM, Bransome ED Jr (1997) Metyrosine and pheochromocytoma. Arch Intern Med 157:901\u2013906","journal-title":"Arch Intern Med"},{"issue":"3","key":"76_CR74","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1210\/jc.2012-3669","volume":"98","author":"RF Stolk","year":"2013","unstructured":"Stolk RF, Bakx C, Mulder J, Timmers HJ, Lenders JW (2013) Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines? J Clin Endocrinol Metab 98(3):1100\u20131106. doi: 10.1210\/jc.2012-3669 , Epub 2013 Feb 13","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"76_CR75","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/0895-7061(96)00057-X","volume":"9","author":"DH Streeten","year":"1996","unstructured":"Streeten DH, Anderson GH Jr (1996) Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. Am J Hypertens 9(8):760\u2013769","journal-title":"Am J Hypertens"},{"issue":"6","key":"76_CR76","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.surg.2008.02.007","volume":"143","author":"VE Strong","year":"2008","unstructured":"Strong VE, Kennedy T, Al-Ahmadie H et al (2008) Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle\/apoptosis gene expression analysis. Surgery 143(6):759\u2013768","journal-title":"Surgery"},{"key":"76_CR77","first-page":"354","volume":"56","author":"MG Sutton","year":"1981","unstructured":"Sutton MG, Sheps SG, Lie JT (1981) Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 56:354","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"76_CR78","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/bjc.2013.365","volume":"109","author":"WC Sze","year":"2013","unstructured":"Sze WC, Grossman AB, Goddard I, Amendra D, Shieh SC, Plowman PN, Drake WM, Akker SA, Druce MR (2013) Sequelae and survivorship in patients treated with (131)I-MIBG therapy. Br J Cancer 109(3):565\u2013572. doi: 10.1038\/bjc.2013.365 , Epub 2013 Jul 16","journal-title":"Br J Cancer"},{"issue":"5","key":"76_CR79","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","volume":"26","author":"LDR Thompson","year":"2002","unstructured":"Thompson LDR (2002) Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26(5):551\u2013566","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"76_CR80","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/jc.2006-2315","volume":"92","author":"HJLM Timmers","year":"2007","unstructured":"Timmers HJLM, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, Lenders JWM, Pacak K (2007) Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-Associated pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 92(3):779\u2013786","journal-title":"J Clin Endocrinol Metab"},{"key":"76_CR81","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1210\/jc.2009-1248","volume":"94","author":"HJ Timmers","year":"2009","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA et al (2009) Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 94:4757\u20134767","journal-title":"J Clin Endocrinol Metab"},{"key":"76_CR82","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1016\/j.jpedsurg.2012.07.003","volume":"47","author":"D Volkin","year":"2012","unstructured":"Volkin D, Yerram N, Ahmed F et al (2012) Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome. J Pediatr Surg 47:2077\u20132082","journal-title":"J Pediatr Surg"},{"key":"76_CR83","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/S0022-5347(05)68171-2","volume":"162","author":"MM Walther","year":"1999","unstructured":"Walther MM, Herring J, Enquist E et al (1999) von Recklinghausen\u2019s disease and pheochromocytomas. J Urol 162:1582","journal-title":"J Urol"},{"key":"76_CR84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5347(17)37119-7","volume":"147","author":"RK Whalen","year":"1992","unstructured":"Whalen RK, Althausen AF, Daniels GH (1992) Extra-adrenal pheochromocytoma. J Urol 147:1","journal-title":"J Urol"},{"key":"76_CR85","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jamcollsurg.2003.12.001","volume":"198","author":"L Yip","year":"2004","unstructured":"Yip L, Lee JE, Shapiro SE et al (2004) Surgical management of hereditary pheochromocytoma. J Am Coll Surg 198:525\u2013534","journal-title":"J Am Coll Surg"},{"key":"76_CR86","volume-title":"Williams textbook of endocrinology","author":"WF Young Jr","year":"2011","unstructured":"Young WF Jr (2011) Endocrine hypertension. In: Melmed S, Polonsky KS, Reed Larsen P, Kronenberg HM (eds) Williams textbook of endocrinology, 12th edn. Elsevier Saunders, Philadelphia","edition":"12"},{"issue":"10","key":"76_CR87","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1056\/NEJMoa1205119","volume":"367","author":"Z Zhuang","year":"2012","unstructured":"Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, Kebebew E, Popovic V, Stratakis CA, Prchal JT, Pacak K (2012) Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med 367(10):922\u2013930. doi: 10.1056\/NEJMoa1205119","journal-title":"N Engl J Med"}],"container-title":["Advances in Experimental Medicine and Biology","Hypertension: from basic research to clinical practice"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2016_76","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T23:51:23Z","timestamp":1568591483000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/5584_2016_76"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319442501","9783319442518"],"references-count":87,"URL":"https:\/\/doi.org\/10.1007\/5584_2016_76","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}